RLM Realm Thera.

TIDMPURI

RNS Number : 3690E

PuriCore Plc

30 May 2012

PuriCore plc Board and Organisational Changes

PuriCore (LSE: PURI), the water-based clean technology company, today announces changes in the executive management team and the Board of Directors. Greg Bosch, Chief Executive Officer, and the Board of Directors have mutually agreed that Mr Bosch will leave the Company and the Board with effect from 31 May 2012, whilst providing transition support through June. Michael Ashton, currently Non-Executive Chairman, will assume the role of Executive Chairman and will manage the Company as a succession plan is developed.

Michael Ashton, Executive Chairman, said:

"Greg has contributed significantly to building the global PuriCore business over the past seven years. He leaves us as a respected colleague as he looks forward to entering the next phase of his career. The Board and I personally thank him for his insight and contribution during his tenure and wish him well in the future. Building on the foundation of two good quarters, I look forward to working actively with our excellent management team and staff to continue to leverage opportunities to build value for our shareholders."

Enquiries:

 
 UK                         US 
 FTI Consulting             Sage Strategic Marketing 
 Ben Brewerton              Jennifer Guinan 
 Victoria Foster Mitchell   +1 610.410.8111 
 +44 (0) 20 7831 3113       jennifer@sagestrat.com 
 

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. The Company's technologies are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.

To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLFFEFETIAFIF

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024